51 filings
Page 2 of 3
8-K
w30ulid907s 3x
30 Oct 23
Regulation FD Disclosure
8:05am
8-K
pzatituzd41o qg
24 Oct 23
Other Events
8:05am
8-K/A
h9fau
19 Oct 23
Financial Statements and Exhibits
5:23pm
8-K
mvr6 zkomnl17r
5 Oct 23
Index to Financial Statements
5:12pm
8-K
08aq9izd5devm96o
29 Sep 23
Entry into a Material Definitive Agreement
5:24pm
8-K
l5ymnbw9qej
29 Sep 23
Submission of Matters to a Vote of Security Holders
3:11pm
8-K
k0o6hs7m8g2v90c4
22 Sep 23
Entry into a Material Definitive Agreement
12:55pm
8-K
2mvc9owp44ms62lc2
22 Sep 23
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting
9:26am
8-K
15b0cscp aiqj
19 Sep 23
Entry into a Material Definitive Agreement
3:51pm
8-K
k4blyxexce3ca
18 Sep 23
Entry into a Material Definitive Agreement
9:25am
8-K
viesg31
14 Sep 23
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting
9:30am
8-K
f11tu05kzw
11 Sep 23
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting
11:30am
8-K
9h8gate
30 Aug 23
Graf Acquisition Corp. IV Announces Intent to Adjourn Special Meeting
7:30am
8-K
oqnfiqiq0bxkdkq 88
15 Aug 23
Graf Acquisition Corp. Iv and Nkgen Biotech, Inc. Announce Effectiveness of Form S-4 for Proposed Business Combination
4:30pm
8-K
smg 27j21d
26 Jul 23
For Investor Use Only For Investor Use Only Maximizing Immune Integrity Investor Event Presentation July 2023
11:54am
8-K
jnmsqw7lr
17 Jul 23
NKGen Biotech Presents Interim Phase I Trial Data at 2023 Alzheimer’s Association International Conference
8:00am
8-K
bpc 45uceeen7lk
5 Jun 23
Regulation FD Disclosure
8:30am
8-K
ru683x0uzg
31 May 23
Confidential Confidential Maximizing Immune Integrity Corporate Presentation May 2023
9:45pm
8-K
xj6fr
22 May 23
Amendments to Articles of Incorporation or Bylaws
9:03pm
8-K
6df4kc5pc2wst4 oqhq
17 Apr 23
Entry into a Material Definitive Agreement
6:01am